Primer: Xiamen Yan Palace Bioengineering (XIAMEN HK) - Aug 2026
Xiamen Yan Palace Bioengineering is a leading player in China's high-growth edible bird's nest (EBN) market, benefiting from strong brand...
89 Views
HK Strategy: How to Play the Future H IPOs of the As
H-share IPOs of A-shares have seen a 30.2% increase in share prices YTD, with a growth outlook driving performance and narrowing H-A discounts....
634 Views
Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention
As Yan palace's revenue growth further declines, effectiveness of marketing activities has already decrease. Huge selling expenses erode profit...
532 Views
Pre-IPO Xiamen Yan Palace Bioengineering - Concerns About Profitability and Growth Sustainability
Since the efficacy/actual value of EBN is questionable, marketing/promotion alone cannot drive future performance growth.Yan Palace's profit model...
699 Views
ECM Weekly (25th June 2023) - Tryt, Shiyue Daotian, Keep, SML, HDFC, Shriram, Tata Tech, Doosan, J&T
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
612 Views